gene

DES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

199Connections
6Hypotheses
30Analyses
50Outgoing
50Incoming

Summary

DES is a gene implicated in neurodegeneration research. Key relationships include: activates, implicated in, associated with. Associated with ALS, Aging, Als. Connected to 115 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolDES
Full NameDesmin
Chromosome2q35
Functionis a critical structural component of muscle cells[@paulin2004].
Molecular Weight53 kDa
Amino Acids470 aa
PathwaysAngiogenesis, Apoptosis, Autophagy, Ferroptosis, Necroptosis
UniProt IDP17661
NCBI Gene ID1674
Ensembl IDENSG00000175084
OMIM125660
GeneCardsDES
Human Protein AtlasDES
N-terminal head domain (residues 1-99)Contains phosphorylation sites and regulates filament assembly
Central rod domain (residues 100-411)Consists of four alpha-helical segments (1A, 1B, 2A, 2B) separated by linkers, responsible for dimerization and filament assembly
Associated DiseasesAging, Als, Alzheimer, Cancer, Cardiac, Cardiovascular
InteractionsMCU, BECN1, SLC7A11, RIPK1, FADD, NRP1
KG Connections199 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: DES — AlphaFold P17661 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

DES Gene

gene · 1159 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Novel Therapy Index

idea · 10647 words

Parkinson's Disease

disease · 8807 words

Parthanatos in Neurodegeneration

mechanism · 6619 words

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

therapeutic · 6350 words

Pathway Diagram

graph TD
    DES["<b>DES</b>"]
    SMOC2["SMOC2"]
    DES -->|"co expressed with"| SMOC2
    DSP["DSP"]
    DES -->|"co expressed with"| DSP
    GJA1["GJA1"]
    DES -->|"co expressed with"| GJA1
    myofibrillar_myopathy{"myofibrillar myopathy"}
    DES -->|"causes"| myofibrillar_myopathy
    Aging{"Aging"}
    DES -->|"activates"| Aging
    Ms{"Ms"}
    DES -->|"activates"| Ms
    Cancer{"Cancer"}
    DES -->|"associated with"| Cancer
    Als{"Als"}
    DES -->|"therapeutic target"| Als
    DES -->|"therapeutic target"| Aging
    Tumor{"Tumor"}
    DES -->|"therapeutic target"| Tumor
    Longevity{"Longevity"}
    DES -->|"therapeutic target"| Longevity
    DES -->|"associated with"| Ms
    MCU["MCU"]
    MCU -->|"activates"| DES
    SLC7A11["SLC7A11"]
    SLC7A11 -->|"activates"| DES
    BECN1["BECN1"]
    BECN1 -->|"activates"| DES
    GENES["GENES"]
    GENES -->|"therapeutic target"| DES
    AMPK["AMPK"]
    AMPK -->|"activates"| DES
    ABCB1["ABCB1"]
    ABCB1 -->|"associated with"| DES
    FAS["FAS"]
    FAS -->|"interacts with"| DES
    CASP8["CASP8"]
    CASP8 -->|"interacts with"| DES
    CASP6["CASP6"]
    CASP6 -->|"interacts with"| DES
    MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"]
    MITOCHONDRIAL_DYSFUNCTION -->|"activates"| DES
    APOPTOSIS["APOPTOSIS"]
    APOPTOSIS -->|"activates"| DES
    CANCER["CANCER"]
    CANCER -->|"associated with"| DES
    style DES fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (142)

TargetRelationTypeStr
Myofibrillar Myopathycausesdisease0.95
GJA1co_expressed_withgene0.80
SMOC2co_expressed_withgene0.80
DSPco_expressed_withgene0.80
Tumoractivatesdisease0.75

Incoming (57)

SourceRelationTypeStr
MCUactivatesgene0.60
SLC7A11activatesgene0.60
BECN1activatesgene0.60
ABCB1associated_withgene0.60
FASinteracts_withgene0.60

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T 0.579 neurodegeneration Should microtubule-stabilizing drugs be
Competitive APOE4 Domain Stabilization Peptides 0.561 neurodegeneration APOE4 structural biology and therapeutic
Vascular mural cell degeneration precedes and exacerbates pa 0.520 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides 0.509 neurodegeneration Blood-brain barrier transport mechanisms
Synthetic Biology Approach: Designer Mitochondrial Export Sy 0.358 neurodegeneration Mitochondrial transfer between neurons a
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m 0.348 neurodegeneration Mitochondrial transfer between astrocyte

Mentioning Analyses (30)

Scientific analyses that reference this entity

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.609

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.567

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] Litvinchuk A, Suh JH, Guo JL, Lin K, Dav Neuron 2024 1
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] Maxine R Nelson, Peng Liu, Ayushi Agrawa Nature neuroscience 2023 1
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] Calvier L, Herz J, Hansmann G JACC Basic Transl Sci 2022 1
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. [PMID:36348357] Raulin AC, Doss SV, Trottier ZA, Ikezu T Mol Neurodegener 2022 1
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] Serrano-Pozo A, Das S, Hyman BT Lancet Neurol 2021 1
Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] Banik SM, Pedram K, Wisnovsky S, Ahn G, Nature 2020 1
Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventin [PMID:30595089] Brophy ML, Dong Y, Tao H, Yancey PG, Son Circ Res 2019 1
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] Long JM, Holtzman DM Cell 2019 1
KIF5A de novo mutation associated with myoclonic seizures and neonatal onset pro [PMID:27414745] Rydzanicz M, Jagła M, Kosinska J, Tomasi Clin Genet 2017 1
Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical [PMID:28381441] Shinohara M, Tachibana M, Kanekiyo T, Bu J Lipid Res 2017 1
TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and [PMID:23395375] van Spronsen M, Mikhaylova M, Lipka J, S Neuron 2013 1
Delineation of the TRAK binding regions of the kinesin-1 motor proteins. [PMID:24161670] Randall TS, Moores C, Stephenson FA FEBS Lett 2013 1
Integrating biocatalysis with continuous flow: current status, challenges, and f [PMID:40639553] Bai J, Huang C, Liu Y, Zheng X, Liu J et J Adv Res 2026 0
Engineering chimeric signaling proteins for microbial whole-cell biosensors: fro [PMID:40903364] Özer Bergman G, Mecacci S, Martins Dos S Trends Biotechnol 2026 0
MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario. [PMID:41512197] Rodon J, Johnson ML, George B, Shah PA, Cancer Res 2026 0
Engineering the Caenorhabditis elegans genome with a nested, self-excising selec [PMID:41557645] Gibney TV, Pani AM Genetics 2026 0
Design and synthesis of BAP-1 inhibitors. [PMID:41761813] Zhang Z, Yang X Pak J Pharm Sci 2026 0
Optimized bacterial expression of a synthetic BRIL antibody. [PMID:41842660] Cooper BF, Isom GL Acta Crystallogr F Struct Biol 2026 0
Chemogenetic Modulation of Luciferase Emission Color for Imaging and Sensing. [PMID:41941277] Manirakiza H, Shpinov Y, Gontier A, El H ACS Sens 2026 0
A Constrained Degron Tag Engineered to Enhance Auxin-Inducible Protein Degradati [PMID:41941339] Han Z, Alkhadrawi A, Tofani S, Zhang W, ACS Synth Biol 2026 0